Giles K, et al. Real-world efficacy of delayed-release dimethyl fumarate in early multiple sclerosis: interim results from ESTEEM. ECTRIMS 2018, P595.
Genetisch risico hemochromatose geassocieerd met ijzerstapeling en bewegingsstoornissen
aug 2022 | Bewegingsstoornissen